Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: even more logic

Bushleague made a great point yesterday.

A grant / business resolution is a royalty. The royalty payments are made every quarter... PTSC doesnt have to show the remaining balance as an accounts receivable.......

Eg. 20 Milion paid over 3 years... 12 payments for the 12 total quarters.

That equals 1.6 million per quarter..... thats why the revenue looks smaller...but in fact we have the money coming in every quarter.

Before a company paid a lumps sum (some may continue).. therefore the revenue is recogized right away.... as cash or accounts receviable.

That is would be the best case.....

The worst case is that TPL/PTSC decided to settled for less with the remaining J3 as they successfull licensed Fujustiu, Sony, NEC, ...at fulll prices...

But personally i dont think they would have done this... as it would and could negatively affect future licensing....

Share
New Message
Please login to post a reply